Poly Medicure Ltd Share Price

Overview

Poly Medicure Ltd share price is currently ₹1,740.01, down by - ₹18.65 (1.06%) from its previous closing price of ₹1,758.66. The share price has gained 4.62% over the past month and declined -10.36% over the past year. The stock's 52-week low and high are ₹1,160.47 and ₹2,109.69, respectively. Poly Medicure Ltd has a market capitalisation of ₹ 18,110.00 Cr. The share price was last updated on 19 Aug 2026, 03:53 PM IST.

Poly Medicure Ltd

POLYMED

₹0.00

- ₹18.65

1.06%

Healthcare

₹0.00(%)1D

Updated: 19 Aug 2026, 03:53:27 pm IST

Market Data

Open Price

₹1,755.98

Prev. Close

₹1,758.66

₹1,724.61

Day Low

₹1,785.52

Day High

₹1,160.47

52 Week Low

₹2,109.69

52 Week High

HealthcareMedical Equipment/Supplies/Accessories

CategoryMid Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

55.97

Sector PE

42.16

PB Ratio

5.69

Sector PB

5.82

EPS

31.09

Dividend Yield

0.29

Today's Volume

100.392 K

5 Day Avg. Volume

148.709 K

PEG Ratio

-11.47

Market Cap.

₹ 18,110.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Actions	Ex-Date	Record-Date
DividendsFinal Dividend of 70% at ₹3.5/Share	28-Aug-2026	29-Aug-2026
DividendsFinal Dividend of 70% at ₹3.5/Share	18-Sep-2025	18-Sep-2025
DividendsFinal Dividend of 60% at ₹3/Share	19-Sep-2024	20-Sep-2024

Mutual Fund Ownership

Mutual Fund Holder	Jun 26 Shares held	Jul 26 Shares held
Quant Small Cap Fund - Growth	43.57 Lac	43.57 Lac no change
UTI Flexi Cap Fund - Regular Plan - IDCW	14.06 Lac	14.06 Lac no change
HSBC Midcap Fund - Regular Plan - Growth	7.72 Lac	8.76 Lac (13.51%)
SBI Healthcare Opportunities Fund - Regular Plan - IDCW	6.40 Lac	6.40 Lac no change
SBI MNC Fund - Regular Plan - IDCW	5.60 Lac	5.60 Lac no change

Show all holdings

About Poly Medicure Ltd 👋

Poly Medicure Limited is an India-based medical device manufacturer and exporter, with its products sold in over 125 countries. The Company is primarily in the business of manufacturing and selling medical devices. With a portfolio of over 200 medical devices and more than 330 patents, the Company offers a comprehensive range of medical devices across 12 medical therapies, including infusion therapy, vascular access, dialysis and renal care, critical care, cardiology, oncology, transfusion, diagnostics, gastroenterology, anesthesia and respiratory care, urology, and surgery and wound management. Its products consist of an I.V. cannula, arterial cannula, prefilled syringe, nasogastric feeding tube, gastro-duodenal feeding tube, umbilical catheter, irrigation sets, urine drainage catheters and others.